Response to letter to the Editor.

Autor: Garduño-Sánchez S; Department of Radiation Oncology, Puerta del Mar University Hospital, Ana de Viya 21 Avenue, 11009, Cádiz, Spain. saragardu@gmail.com.; Biomedical Research and Innovation Institute of Cádiz (INiBICA) Research Unit, Puerta del Mar University Hospital, Cádiz, Spain. saragardu@gmail.com., Villanego-Beltrán I; Department of Radiation Oncology, Puerta del Mar University Hospital, Ana de Viya 21 Avenue, 11009, Cádiz, Spain.; Biomedical Research and Innovation Institute of Cádiz (INiBICA) Research Unit, Puerta del Mar University Hospital, Cádiz, Spain., de Las Peñas-Cabrera MD; Department of Radiation Oncology, Puerta del Mar University Hospital, Ana de Viya 21 Avenue, 11009, Cádiz, Spain.; Department of Radiation Oncology, Rey Juan Carlos University Hospital, Gladiolo s/n, 28933, Madrid, Spain., Jaén-Olasolo J; Department of Radiation Oncology, Puerta del Mar University Hospital, Ana de Viya 21 Avenue, 11009, Cádiz, Spain.; Biomedical Research and Innovation Institute of Cádiz (INiBICA) Research Unit, Puerta del Mar University Hospital, Cádiz, Spain.
Jazyk: angličtina
Zdroj: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2022 Sep; Vol. 24 (9), pp. 1831-1832. Date of Electronic Publication: 2022 Mar 30.
DOI: 10.1007/s12094-022-02828-5
Databáze: MEDLINE
Externí odkaz: